Results 221 to 230 of about 12,340,531 (359)

Large models in medical imaging: Advances and prospects. [PDF]

open access: yesChin Med J (Engl)
Fang M   +10 more
europepmc   +1 more source

Software programmable multi-mode interface for nuclear-medical imaging

open access: green, 1982
I. George Zubal   +4 more
openalex   +1 more source

Medical visualization---why we use CG and does it REALLY make a difference in creating meaningful images (panel) [PDF]

open access: bronze, 1997
Virginia E. McArthur   +5 more
openalex   +1 more source

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

open access: yesMolecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece   +18 more
wiley   +1 more source

Machine Learning in Medical Imaging

open access: yesInternational Journal of Biomedical Imaging, 2012
Kenji Suzuki   +3 more
doaj   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

open access: yesMolecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir   +2 more
wiley   +1 more source

Terminology describing medical imaging professionals

open access: yesJournal of Medical Radiation Sciences, 2019
Warren Reed
doaj   +1 more source

Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor‐adapted non‐small cell lung cancer cell lines

open access: yesFEBS Open Bio, EarlyView.
Phenotypic plasticity in a newly established set of EGFR inhibitor‐adapted NSCLC cell lines during adaptation and in established cell lines. Here, we introduce novel sublines of the EGFR‐mutant non‐small cell lung cancer (NSCLC) cell lines HCC827 and HCC4006 adapted to the EGFR kinase inhibitors gefitinib (HCC827rGEFI2μm, HCC4006rGEFI1μm), erlotinib ...
Tharsagini V. Nanthaprakash   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy